Perrigo (PRGO) FCF Payout Ratio Growth (1y) (2014 - 2026)
Perrigo (PRGO) FCF Payout Ratio Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn | -14.68% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -49.97% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -49.30% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Perrigo | 1.93 Bn | 1.54 Bn | 313.90 Mn | -14.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -14.21% |
| Mar 28, 2026 | 30.57% |
| Dec 31, 2025 | 86.39% |
| Sep 27, 2025 | -46.23% |
| Jun 28, 2025 | 134.39% |
| Mar 29, 2025 | 68.21% |
| Dec 31, 2024 | -30.27% |
| Sep 28, 2024 | 493.39% |
| Jun 29, 2024 | -277.37% |
| Mar 30, 2024 | 85.11% |
| Dec 31, 2023 | -41.76% |
| Sep 30, 2023 | 9.51% |
| Jul 1, 2023 | 243.91% |
| Apr 1, 2023 | -1,737.86% |
| Dec 31, 2022 | 308.48% |
| Oct 1, 2022 | 300.31% |
| Jul 2, 2022 | -153.19% |
| Apr 2, 2022 | 180.64% |
| Dec 31, 2021 | 85.74% |
| Oct 2, 2021 | -80.98% |